Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | KCNN4 | O15554 | 5/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | PGK1 | P00558 | 1/20 | 0.39 |
| ▸ | PGK2 | P07205 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8333825 | 0.80 | PGK1 (0.48) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL28114684 | 0.80 | TSHR (0.52) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL424619 | 0.79 | TSHR (0.58) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL17078011 | 0.74 | ALDH1A1 (0.52) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL17288747 | 0.73 | TSHR (0.58) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL612731 | 0.73 | ALDH1A1 (0.58) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL951559 | 0.73 | TSHR (0.58) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL11546152 | 0.73 | TSHR (0.58) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL160204 | 0.73 | TSHR (0.58) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL146900 | 0.73 | TSHR (0.58) | TSHRALDH1A1PTPN1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11779911-B2 | Production of fatty olefin derivatives via olefin metathesis | PROVIVI, INC. (US) | 2023-10-10 | — | — | US | claimed |
| CN-115215748-A | Production of aliphatic olefin derivatives by olefin metathesis | 普罗维维公司 | 2022-10-21 | — | — | CN | claimed |
| US-20220032280-A1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | PROVIVI, INC. (US) | 2022-02-03 | — | — | US | claimed |
| EP-3019510-B1 | USE OF IMMOBILIZED MOLYBDEN- UND TUNGSTEN-CONTAINING CATALYSTS IN OLEFIN CROSS METATHESIS | VERBIO VER BIOENERGIE AG (DE) | 2020-12-02 | — | — | EP | claimed |
| EP-3662996-A2 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | Verbio Vereinigte BioEnergie AG (DE) | 2020-06-10 | — | — | EP | claimed |
| CN-110603240-A | Synthesis of pheromones and related substances via olefin metathesis | 普罗维维公司 | 2019-12-20 | — | — | CN | claimed |
| EP-2703081-B1 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XIMO AG (CH) | 2019-08-07 | — | — | EP | claimed |
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | XIMO AG (CH) | 2019-07-09 | — | — | US | claimed |
| EP-3377465-A2 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | Provivi, Inc. (US) | 2018-09-26 | — | — | EP | claimed |
| US-10071950-B2 | Use of immobilized molybdenum- and tungsten-containing catalysts in olefin cross metathesis | XIMO AG (CH) | 2018-09-11 | — | — | US | claimed |
| US-20160030936-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2016-02-04 | — | — | US | claimed |
| EP-2969204-A2 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XiMo AG (CH) | 2016-01-20 | — | — | EP | claimed |
| US-20140309466-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2014-10-16 | — | — | US | claimed |
| WO-2014139679-A2 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XIMO AG (CH) | 2014-09-18 | — | — | WO | claimed |
| EP-2703081-A1 | Molybdenum and tungsten complexes as olefin metathesis catalysts and reactions using the catalysts | XiMo AG (CH) | 2014-03-05 | — | — | EP | claimed |
| EP-1292579-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRAZINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | Pharmacia Corporation (US) | 2003-03-19 | — | — | EP | claimed |
| WO-2001087854-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRAZINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2001-11-22 | — | — | WO | claimed |
| WO-2001087851-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIMIDINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2001-11-22 | — | — | WO | claimed |
| WO-2001087842-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIDONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2001-11-22 | — | — | WO | claimed |
| WO-2001087852-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL URACILS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2001-11-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | MSMO1, SQLE, MOGAT2 | TSHR 4219/4885ALDH1A1 994/4885PTPN1 4696/4885 |
| US-20140309466-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | MSMO1, PYM1, SQLE | TSHR 2482/4885ALDH1A1 2361/4885PTPN1 4326/4885 |
| US-20160030936-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | MSMO1, SQLE, PYM1 | TSHR 2403/4885ALDH1A1 1956/4885PTPN1 4333/4885 |
| US-11779911-B2 | Production of fatty olefin derivatives via olefin metathesis | SREBF1, F2, SREBF2 | TSHR 1977/4885ALDH1A1 1913/4885PTPN1 4802/4885 |
| US-20220032280-A1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | SREBF1, F2, SREBF2 | TSHR 1977/4885ALDH1A1 1913/4885PTPN1 4802/4885 |
| US-10071950-B2 | Use of immobilized molybdenum- and tungsten-containing catalysts in olefin cross metathesis | DUOX1, DUOX2, MSN | TSHR 4162/4885ALDH1A1 1742/4885PTPN1 4721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.